Native Apps for US Healthcare: Difference between revisions
Jump to navigation
Jump to search
(Created page with "==Full Title== Status of current regulatory information on the approval of Native Apps for US Healthcare. ==Context== There are three sources of requirements for Native...") |
|||
| Line 5: | Line 5: | ||
# US Cures Act Final Rule of 2020-05-01 - the regulations | # US Cures Act Final Rule of 2020-05-01 - the regulations | ||
# Medicare rules for reimbursement - the hammer behind adoption of the regulations. | # Medicare rules for reimbursement - the hammer behind adoption of the regulations. | ||
# [ | # [https://tcwiki.azurewebsites.net/index.php?title=TEFCA Trusted Exchange Framework and Common Agreement (TEFCA)] | ||
# FDA Medical device regulations | # FDA Medical device regulations | ||
==Issues== | ==Issues== | ||
Revision as of 20:40, 14 August 2020
Full Title
Status of current regulatory information on the approval of Native Apps for US Healthcare.
Context
There are three sources of requirements for Native Apps for US Healthcare:
- US Cures Act Final Rule of 2020-05-01 - the regulations
- Medicare rules for reimbursement - the hammer behind adoption of the regulations.
- Trusted Exchange Framework and Common Agreement (TEFCA)
- FDA Medical device regulations